Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin-Reference-Cited by-同舟云学术

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin

Published:2004-03 Issue:3 Volume:40 Page:527-532
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Buti Maria,Mendez Claudia,Schaper Melanie,Sauleda Silvia,Valdes Auristela,Rodriguez-Frias Francisco,Jardi Rosendo,Esteban Rafael

Publisher

Elsevier BV

Subject

Hepatology

Reference24 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C 2002 (June 10–12, 2002);Anonymous;Gastroenterology,2002

4. Molecular diagnosis of viral hepatitis;Pawlotsky;Gastroenterology,2002

5. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy;Berg;Hepatology,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An automated fast-flow/delayed paper-based platform for the simultaneous electrochemical detection of hepatitis B virus and hepatitis C virus core antigen;Biosensors and Bioelectronics;2021-12

2. Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV infected patients;Antiviral Therapy;2017

3. Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin;Hepatology International;2015-08-12

4. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging;World Journal of Gastroenterology;2014

5. Low-dose pegylated interferon-alpha-2a plus ribavirin therapy for elderly and/or cirrhotic patients with hepatitis C virus genotype-1b and high viral load;Antiviral Therapy;2013